Annual Accounts Payable
$3.08 M
+$722.50 K+30.66%
December 1, 2023
Summary
- As of February 12, 2025, TNFA annual accounts payable is $3.08 million, with the most recent change of +$722.50 thousand (+30.66%) on December 1, 2023.
- During the last 3 years, TNFA annual accounts payable has risen by +$1.28 million (+70.90%).
- TNFA annual accounts payable is now at all-time high.
Performance
TNFA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.71 M
-$387.10 K-9.46%
September 1, 2024
Summary
- As of February 12, 2025, TNFA quarterly accounts payable is $3.71 million, with the most recent change of -$387.10 thousand (-9.46%) on September 1, 2024.
- Over the past year, TNFA quarterly accounts payable has increased by +$626.00 thousand (+20.33%).
- TNFA quarterly accounts payable is now -9.46% below its all-time high of $4.09 million, reached on June 1, 2024.
Performance
TNFA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TNFA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.7% | +20.3% |
| 3 y3 years | +70.9% | +166.0% |
| 5 y5 years | +70.9% | +63.9% |
TNFA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +254.9% | -9.5% | +327.1% |
| 5 y | 5-year | at high | +254.9% | -9.5% | +327.1% |
| alltime | all time | at high | +254.9% | -9.5% | +327.1% |
TNF Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.71 M(-9.5%) |
| Jun 2024 | - | $4.09 M(+22.1%) |
| Mar 2024 | - | $3.35 M(+8.8%) |
| Dec 2023 | $3.08 M(+30.7%) | $3.08 M(+128.4%) |
| Sep 2023 | - | $1.35 M(-18.8%) |
| Jun 2023 | - | $1.66 M(+38.3%) |
| Mar 2023 | - | $1.20 M(-49.1%) |
| Dec 2022 | $2.36 M | $2.36 M(+69.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.39 M(-46.8%) |
| Jun 2022 | - | $2.62 M(+31.2%) |
| Mar 2022 | - | $2.00 M(+130.1%) |
| Dec 2021 | $867.50 K(-51.9%) | $867.50 K(-57.8%) |
| Sep 2021 | - | $2.05 M(-34.3%) |
| Jun 2021 | - | $3.13 M(+38.3%) |
| Mar 2021 | - | $2.26 M(+25.5%) |
| Dec 2020 | $1.80 M | $1.80 M |
FAQ
- What is TNF Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals annual accounts payable year-on-year change?
- What is TNF Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals quarterly accounts payable year-on-year change?
What is TNF Pharmaceuticals annual accounts payable?
The current annual accounts payable of TNFA is $3.08 M
What is the all time high annual accounts payable for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high annual accounts payable is $3.08 M
What is TNF Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, TNFA annual accounts payable has changed by +$722.50 K (+30.66%)
What is TNF Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of TNFA is $3.71 M
What is the all time high quarterly accounts payable for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high quarterly accounts payable is $4.09 M
What is TNF Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, TNFA quarterly accounts payable has changed by +$626.00 K (+20.33%)